| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Exec. VP, Mktg &External Comm
1 company
Harrell James Archie Jr serves as a Chief Commercial Officer at AVTX. Across recent SEC filings that breaks down to 8 buys and 0 sells. Those positions are worth an estimated $58K at current prices.
The biggest single holding is AVTX (~$58K) as Chief Commercial Officer. Net of sales, the recent Form 4 record there shows accumulation of 36,766 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | AVTX Avalo Therapeutics, Inc. | Chief Commercial Officer | Buy | 1,093 | $1.57 | $1,716.01 | +3.1% | -61.9% | -76.6% | |
| Jun 10, 2021 | AVTX Avalo Therapeutics, Inc. | Chief Commercial Officer | Buy | 7,493 | $2.28 | $17,084.04 | +26.6% | -22.9% | -87.0% | |
| Dec 10, 2020 | AVTX Avalo Therapeutics, Inc. | Chief Commercial Officer | Buy | 171 | $2.28 | $389.54 | +0.6% | - | - | |
| Jun 10, 2020 | AVTX Avalo Therapeutics, Inc. | Chief Commercial Officer | Buy | 16,391 | $2.41 | $39,558.70 | +141.1% | - | - | |
| Dec 10, 2019 | AVTX Avalo Therapeutics, Inc. | Chief Commercial Officer | Buy | 3,064 | $2.85 | $8,724.74 | +35.8% | - | - | |
| Jun 10, 2019 | AVTX Avalo Therapeutics, Inc. | Exec. VP, Mktg &External Comm | Buy | 4,398 | $2.85 | $12,523.31 | +105.8% | - | - | |
| Dec 10, 2018 | AVTX Avalo Therapeutics, Inc. | Exec. VP, Mktg &External Comm | Buy | 4,156 | $2.85 | $11,834.21 | New | - | - |